<
 
 
 
 
×
>
You are viewing an archived web page captured at 08:46:01 Mar 21, 2022, which is part of the National Records of Scotland Web Archive. The information on this web page may be out of date. See all captures of this archived page. Archived web pages you visit here may leave cookies in your browser. These are not owned, controlled, or used by NRS. NRS do use cookies, including Google Analytics, to monitor site usage and performance. These can be managed in your browser settings. Find out more about cookies.
Loading media information
hide

Publication - Advice and guidance

Coronavirus (COVID-19): AstraZeneca (ChAdOx1-S [Recombinant]) vaccine - national protocol - edition 2.2

Published: 4 Jun 2021
Part of:
Coronavirus in Scotland, Health and social care
ISBN:
9781800049765

This protocol is for the supply and administration of AstraZeneca COVID-19 Vaccine (ChAdOx1-S [Recombinant]) to individuals in accordance with the national COVID-19 vaccination programme.

Coronavirus (COVID-19): AstraZeneca (ChAdOx1-S [Recombinant]) vaccine - national protocol - edition 2.2
5. Clinical condition or situation to which this Protocol applies

5. Clinical condition or situation to which this Protocol applies

AstraZeneca COVID-19 Vaccine (ChAdOx1-S [Recombinant]) is indicated for active immunisation against COVID-19 disease caused by SARS-CoV-2 virus in accordance with Scottish Government COVID-19 immunisation programme and recommendations given in Chapter 14a of the Immunisation Against Infectious Disease: the 'Green Book' COVID-19: the green book, chapter 14a - GOV.UK (www.gov.uk) and Scottish Government CMO letters relating to COVID-19 vaccination.


Contact

Email: VaccinationsDelivery@gov.scot